How to Get Losartan in Pennsylvania

Prescription access and medication affordability image for How to Get Losartan in Pennsylvania

At a glance

  • Drug class / ARB (angiotensin II receptor blocker), oral tablet
  • Approved indications / hypertension, heart failure (with reduced EF), diabetic nephropathy in type 2 diabetes
  • Telehealth prescribing in PA / Yes, legal under Pennsylvania telehealth statute (Act 44 of 2020)
  • Typical starting dose / 50 mg once daily (range 25 mg to 100 mg)
  • Labs required before prescribing / BMP (creatinine, potassium, eGFR) plus baseline blood pressure
  • Generic retail cost / $10 to $15 for 30 tablets at most PA chain pharmacies
  • PA Medicaid coverage / Covered with prior authorization for hypertension, heart failure, and diabetic nephropathy
  • 503A compounding / Yes, PA-licensed 503A pharmacies may compound losartan for medically necessary formulations
  • Who can prescribe in PA / MD, DO, NP (with prescriptive authority), PA-C (with collaborative agreement)
  • Typical time to first fill / 24 to 72 hours via telehealth; same day for in-person visits

What Is Losartan and Why Is It Prescribed?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three distinct indications: hypertension in adults and children aged 6 and older, reduction of stroke risk in patients with hypertension and left ventricular hypertrophy, and slowing the progression of diabetic nephropathy in adults with type 2 diabetes [1]. It blocks the AT1 receptor, preventing angiotensin II from raising blood pressure and promoting aldosterone release.

The landmark LIFE trial (N=9,193) compared losartan 50 to 100 mg daily against atenolol 50 to 100 mg daily over a mean 4.8 years in patients with hypertension and ECG-confirmed left ventricular hypertrophy. Losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% versus atenolol (relative risk 0.87, P<0.001), driven primarily by a 25% reduction in fatal and non-fatal stroke [2]. The RENAAL trial (N=1,513) separately demonstrated that losartan 100 mg daily reduced the risk of end-stage renal disease by 28% compared with placebo in patients with type 2 diabetes and nephropathy (P<0.002) [3].

Generic losartan potassium is manufactured by multiple companies and is listed on the FDA Orange Book as therapeutically equivalent to branded Cozaar [4]. The American Heart Association and American College of Cardiology 2023 Hypertension Guideline list ARBs as first-line antihypertensive agents alongside ACE inhibitors, thiazide diuretics, and calcium channel blockers [5].

Pennsylvania Telehealth Law and Losartan Prescribing

Pennsylvania fully permits telehealth prescribing of losartan. Act 44 of 2020 amended Title 63 of the Pennsylvania Consolidated Statutes to allow licensed Pennsylvania prescribers to evaluate, diagnose, and prescribe via real-time audio-video platforms without a prior in-person visit, provided the standard of care is met [6]. Losartan is a schedule-exempt medication, meaning no DEA controlled-substance exemption is required. A prescriber may issue a valid Pennsylvania prescription entirely through a telehealth encounter.

The Pennsylvania State Board of Medicine requires that a telehealth provider establish a provider-patient relationship before prescribing. In practice, this means a synchronous video visit during which the provider reviews your blood pressure readings, medication history, and lab results. Asynchronous-only (text or image) encounters are not sufficient for an initial losartan prescription under current Board guidance [7].

HealthRX connects Pennsylvania patients with board-certified physicians and nurse practitioners who hold active Pennsylvania licenses. Visits are typically completed within 24 hours. After prescriber sign-off, the prescription is sent electronically to your chosen Pennsylvania pharmacy or a mail-order pharmacy licensed in Pennsylvania.

Required Labs and Baseline Assessment Before Prescribing

Labs are not optional. Losartan can raise serum potassium and reduce renal filtration, particularly in patients with pre-existing chronic kidney disease or those taking potassium-sparing diuretics [8]. The FDA prescribing label states that periodic monitoring of serum electrolytes and renal function is required during therapy [1].

Before a Pennsylvania prescriber can safely initiate losartan, you will need:

  1. Basic metabolic panel (BMP) including serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and serum potassium. A potassium above 5.0 mEq/L at baseline is a relative contraindication requiring prescriber review [9].
  2. Blood pressure measurement on at least two occasions. Home readings taken with a validated cuff on two separate days are accepted by most Pennsylvania telehealth providers.
  3. Pregnancy status confirmation in women of childbearing age. Losartan is FDA Pregnancy Category D; use in the second and third trimester causes fetal renal dysplasia and is contraindicated [1].

If you have an eGFR <30 mL/min/1.73m², dose adjustment and closer monitoring are required. Patients with bilateral renal artery stenosis should not use ARBs without a nephrology consultation [10]. Labs drawn within the past 6 months at any CLIA-certified Pennsylvania laboratory are generally accepted by telehealth providers. Quest Diagnostics and LabCorp each operate more than 40 patient service centers across Pennsylvania.

Who Can Prescribe Losartan in Pennsylvania

Multiple license types may prescribe losartan in Pennsylvania, each under different regulatory frameworks.

Medical Doctors (MD) and Doctors of Osteopathic Medicine (DO) hold full independent prescriptive authority under the Pennsylvania Medical Practice Act (63 P.S. §422.1 et seq.) and may prescribe losartan without restriction [11].

Certified Registered Nurse Practitioners (CRNP) in Pennsylvania may prescribe Schedule II through V controlled substances and all non-controlled medications, including losartan, under a Collaborative Agreement with a physician [12]. Act 112 of 2023 expanded CRNP prescriptive authority in Pennsylvania, reducing some collaborative requirements for experienced practitioners.

Physician Assistants (PA-C) may prescribe losartan under a written supervisory agreement with a supervising physician, consistent with the Pennsylvania Physician Assistant Practice Act [13].

All three license types can prescribe via telehealth. When using an online platform, confirm that your provider holds an active Pennsylvania license by searching the Pennsylvania Department of State Licensing System at www.dos.pa.gov.

How to Get a Losartan Prescription: Step-by-Step

Getting losartan in Pennsylvania involves a predictable sequence. The steps below apply whether you use an in-person provider or a telehealth service.

Step 1. Gather your labs. Get a BMP drawn at a local Pennsylvania lab. Many platforms can order labs on your behalf before your visit.

Step 2. Document your blood pressure. Record two readings on separate days using a validated home monitor. The AHA defines hypertension as a sustained systolic at or above 130 mmHg or diastolic at or above 80 mmHg [5].

Step 3. Complete the clinical visit. A prescriber reviews your labs, blood pressure history, current medications, and any relevant medical history. The visit takes 10 to 20 minutes via telehealth.

Step 4. Receive your electronic prescription. Pennsylvania participates in the national EPCS (electronic prescribing of controlled substances) infrastructure, but losartan is non-controlled, so standard e-prescribe applies. The prescriber sends the Rx directly to your chosen pharmacy.

Step 5. Fill at a licensed Pennsylvania pharmacy. Any Pennsylvania-licensed retail pharmacy, mail-order pharmacy, or 503A compounding pharmacy may fill the prescription. Expect 24 to 72 hours for telehealth-initiated prescriptions and same-day fill for in-person visits.

Pennsylvania Pharmacy Options: Retail, Mail-Order, and 503A Compounding

Standard losartan potassium 25 mg, 50 mg, and 100 mg tablets are available at all major Pennsylvania retail chains including CVS, Rite Aid, Walmart Pharmacy, and Giant Pharmacy. The GoodRx price for 30 tablets of losartan 50 mg in Philadelphia ranges from $10 to $13, which is below the Pennsylvania Medicaid reimbursement rate for the same quantity [14].

Mail-order pharmacies licensed in Pennsylvania include Express Scripts, CVS Caremark, and Optum Rx. Pennsylvania law permits out-of-state mail-order pharmacies to ship to Pennsylvania residents if they hold a Pennsylvania Non-Resident Pharmacy License issued by the State Board of Pharmacy [15]. A 90-day mail-order supply of generic losartan typically costs $20 to $30 through major pharmacy benefit managers.

503A compounding pharmacies in Pennsylvania are regulated by the Pennsylvania State Board of Pharmacy under the federal Drug Quality and Security Act (DQSA) and USP Chapter 795 standards [16]. A 503A pharmacy may compound a customized losartan formulation, such as an oral suspension for patients who cannot swallow tablets, when a prescriber documents a medical necessity. Pennsylvania currently licenses more than 80 503A compounding pharmacies. These facilities cannot produce commercial-scale batches or ship to patients in other states without additional 503B outsourcing facility status [17].

Pennsylvania Medicaid (Medical Assistance) covers losartan for hypertension, heart failure, and diabetic nephropathy with prior authorization. The PA Department of Human Services Preferred Drug List as of 2024 includes generic losartan as a preferred ARB [18].

Prior Authorization for Losartan in Pennsylvania

Prior authorization (PA) for losartan is required by many Pennsylvania commercial insurers and by Pennsylvania Medicaid for certain indications. The documentation your prescriber will need includes:

  • Diagnosis code (ICD-10: I10 for essential hypertension, I50.x for heart failure, N18.x for chronic kidney disease with diabetic nephropathy).
  • Evidence of a trial or contraindication to a preferred formulary agent if the insurer requires step therapy. Pennsylvania's Act 146 of 2016 (the Step Therapy Reform Act) limits insurers to one step-therapy requirement before approving an ARB when a prescriber documents clinical necessity [19].
  • Recent lab values confirming eGFR and potassium within acceptable range.
  • Blood pressure readings confirming diagnosis of hypertension.

Pennsylvania's step therapy law requires that insurers respond to a PA exception request within 72 hours for non-urgent cases and 24 hours for urgent cases. If the insurer denies authorization, the prescriber may file an expedited appeal. The Pennsylvania Insurance Department oversees compliance [19].

Most prior authorization requests for generic losartan are approved on first submission when supporting documentation is complete. Denials typically occur when a patient has not trialed a thiazide diuretic first, which is the most common insurer step-therapy requirement for ARBs.

Transferring a Losartan Prescription to Pennsylvania

If you move to Pennsylvania or switch pharmacies, transferring a losartan prescription is straightforward. Pennsylvania pharmacy law allows a pharmacist to accept a prescription transfer from any out-of-state licensed pharmacy for a non-controlled medication [20]. The receiving Pennsylvania pharmacy contacts the originating pharmacy directly. You do not need a new prescription from a Pennsylvania provider unless your existing Rx has zero refills remaining.

If you have zero refills, a Pennsylvania prescriber must issue a new prescription. A telehealth visit is the fastest route. Most telehealth platforms can complete the evaluation and transmit the new Rx to a Pennsylvania pharmacy within 24 hours of your visit.

Pennsylvania pharmacists may dispense an emergency 30-day supply of a chronic medication, including losartan, if refills are exhausted and the prescriber cannot be immediately reached, under Pennsylvania State Board of Pharmacy emergency dispensing rules [20]. The pharmacist must document the dispensing and notify the prescriber within 72 hours.

Dosing, Monitoring, and Safety Considerations

The FDA-approved starting dose for hypertension in most adults is 50 mg once daily, with a maintenance range of 25 mg to 100 mg daily in one or two divided doses [1]. Patients with volume depletion or hepatic impairment should start at 25 mg daily to reduce the risk of first-dose hypotension [1].

For diabetic nephropathy, the target dose established in the RENAAL trial was 100 mg once daily, which produced a 28% reduction in the risk of doubling serum creatinine or reaching ESRD [3]. The American Diabetes Association 2024 Standards of Care recommend an ARB or ACE inhibitor as first-line antihypertensive therapy in adults with type 2 diabetes and albuminuria, with a target blood pressure below 130/80 mmHg [21].

Post-initiation monitoring should include a repeat BMP at 2 to 4 weeks after starting or dose-adjusting losartan [8]. Hyperkalemia (potassium above 5.5 mEq/L) or a rise in creatinine greater than 30% from baseline within 4 weeks of starting therapy warrants dose reduction or discontinuation and nephrology referral [9].

Losartan should not be combined with aliskiren in patients with diabetes or an eGFR <60 mL/min/1.73m², per FDA label [1]. Dual renin-angiotensin-aldosterone system (RAAS) blockade using both an ACE inhibitor and an ARB is not recommended in the 2023 ACC/AHA Hypertension Guideline due to increased risk of acute kidney injury and hyperkalemia without additional cardiovascular benefit [5].

Common adverse effects include dizziness (reported in 3% of patients in clinical trials), upper respiratory infection (8%), and back pain (2%) [1]. Unlike ACE inhibitors, losartan carries less than a 1% rate of drug-induced cough because it does not inhibit bradykinin degradation [22]. This pharmacological difference makes losartan a preferred alternative for patients who develop ACE inhibitor-induced cough, as noted in the JNC 8 panel report published in JAMA [23].

The 2023 ACC/AHA Hypertension Guideline states: "ARBs are preferred over ACE inhibitors in patients who have experienced ACE inhibitor-induced cough, since the incidence of cough with ARBs is similar to placebo" [5].

Cost and Assistance Programs for Pennsylvania Patients

Generic losartan is one of the least expensive antihypertensives on the market. The Pennsylvania PACE and PACENET programs provide subsidized medication costs for Pennsylvania residents aged 65 and older who meet income criteria [24]. PACENET covers up to $500 in drug costs per month for enrollees. Losartan qualifies as a covered medication under both programs.

The NeedyMeds database lists three manufacturer patient assistance programs and four state-based programs that cover losartan for uninsured or underinsured Pennsylvania residents [25]. Merck's Merck Helps program provides brand-name Cozaar at no cost to qualifying patients, though most providers prescribe the generic given bioequivalence.

GoodRx, RxSaver, and the NACo Prescription Discount Card are accepted at most Pennsylvania retail pharmacies and can reduce out-of-pocket costs to under $15 for a 90-day supply of generic losartan 50 mg in most Pennsylvania ZIP codes.

Frequently asked questions

How do I get a losartan prescription in Pennsylvania?
You can get a losartan prescription in Pennsylvania through an in-person visit with a licensed PA physician, DO, NP, or PA-C, or through a Pennsylvania-licensed telehealth provider. You will need a basic metabolic panel showing kidney function and potassium levels, plus documented blood pressure readings. After a clinical evaluation, the prescriber sends an electronic prescription directly to your chosen pharmacy.
What labs are needed before starting losartan in Pennsylvania?
A basic metabolic panel (BMP) is required before any prescriber in Pennsylvania can safely initiate losartan. The panel must include serum creatinine, BUN, eGFR, and potassium. Women of childbearing age also need a confirmed negative pregnancy test, as losartan is contraindicated in the second and third trimester of pregnancy. Labs drawn within the past 6 months at a CLIA-certified lab are generally accepted.
Are there telehealth providers in Pennsylvania prescribing losartan?
Yes. Pennsylvania Act 44 of 2020 explicitly permits telehealth prescribing of non-controlled medications including losartan. Multiple platforms, including HealthRX, connect Pennsylvania residents with PA-licensed physicians and nurse practitioners who can evaluate and prescribe losartan via synchronous video visit without a prior in-person encounter.
How long until I receive losartan in Pennsylvania?
For telehealth-initiated prescriptions, the typical timeline is 24 to 72 hours from visit completion to pharmacy fill. In-person prescriptions can be filled the same day. Mail-order pharmacies add 3 to 7 business days for delivery. Emergency 30-day supplies may be dispensed same-day by a Pennsylvania pharmacist when a refill is urgently needed.
Can I transfer a losartan prescription to Pennsylvania?
Yes. Pennsylvania pharmacy law allows any PA-licensed pharmacy to accept a transfer of a non-controlled medication prescription from an out-of-state pharmacy. The receiving pharmacy contacts the originating pharmacy to complete the transfer. If you have no refills remaining, a new prescription from a Pennsylvania-licensed provider is required, which can be obtained via a telehealth visit.
Are 503A pharmacies in Pennsylvania licensed to ship losartan?
Pennsylvania-licensed 503A compounding pharmacies may dispense compounded losartan formulations (such as oral suspensions) to Pennsylvania patients with a valid prescription documenting medical necessity. They may not ship to patients in other states unless they also hold 503B outsourcing facility registration. The Pennsylvania State Board of Pharmacy maintains the current list of licensed 503A facilities.
Who can prescribe losartan in Pennsylvania?
In Pennsylvania, losartan may be prescribed by licensed Medical Doctors (MD), Doctors of Osteopathic Medicine (DO), Certified Registered Nurse Practitioners (CRNP) operating under a Collaborative Agreement, and Physician Assistants (PA-C) under a supervisory agreement. All four license types may prescribe via telehealth. You can verify any provider's Pennsylvania license at the Department of State licensing portal.
What documentation does prior authorization require in Pennsylvania?
Pennsylvania insurers typically require the ICD-10 diagnosis code (I10 for hypertension, I50.x for heart failure, or N18.x for diabetic nephropathy), recent lab values showing eGFR and potassium, blood pressure records confirming the diagnosis, and documentation of a trial or contraindication to any formulary-preferred agent required by step therapy. Pennsylvania's Step Therapy Reform Act (Act 146 of 2016) limits step-therapy to one prior agent and requires insurer response within 72 hours for non-urgent requests.
What is the usual losartan dose for hypertension in adults?
The FDA-approved starting dose for hypertension in most adults is 50 mg once daily. The dose may be titrated to a maximum of 100 mg daily in one or two divided doses based on blood pressure response. Patients with hepatic impairment or volume depletion should start at 25 mg daily to reduce first-dose hypotension risk.
Does Pennsylvania Medicaid cover losartan?
Yes. Pennsylvania Medicaid (Medical Assistance) covers generic losartan for hypertension, heart failure, and diabetic nephropathy with prior authorization. Generic losartan is listed as a preferred ARB on the Pennsylvania Department of Human Services Preferred Drug List. The PACE and PACENET programs provide additional prescription cost assistance for Pennsylvania residents aged 65 and older who meet income criteria.

References

  1. FDA. Cozaar (losartan potassium) prescribing information. Accessed July 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
  2. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE). Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
  3. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
  4. FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Losartan potassium. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  5. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  6. Pennsylvania General Assembly. Act 44 of 2020: Telemedicine. Title 63 Pa.C.S. https://www.legis.state.pa.us/cfdocs/legis/li/uconsCheck.cfm?yr=2020&sessInd=0&act=44
  7. Pennsylvania State Board of Medicine. Telehealth Guidance. https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Medicine/Pages/default.aspx
  8. Sica DA, Gehr TWB. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in the treatment of hypertension: focus on renal and cardiac protection. Curr Hypertens Rep. 2002;4(6):479-490. https://pubmed.ncbi.nlm.nih.gov/12401145/
  9. Weir MR. Effects of renin-angiotensin-aldosterone system inhibition on potassium homeostasis. Am J Med. 2007;120(4 Suppl 1):S10-S18. https://pubmed.ncbi.nlm.nih.gov/17403392/
  10. Textor SC. Renal arterial disease and hypertension. Med Clin North Am. 2017;101(1):65-79. https://pubmed.ncbi.nlm.nih.gov/27884231/
  11. Pennsylvania Medical Practice Act, 63 P.S. §422.1 et seq. Pennsylvania General Assembly. https://www.legis.state.pa.us/WU01/LI/LI/CT/HTM/63/00.422.001.000..HTM
  12. Pennsylvania State Board of Nursing. CRNP Prescriptive Authority. https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Nursing/Pages/default.aspx
  13. Pennsylvania Physician Assistant Practice Act, 63 P.S. §422.37 et seq. https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/PhysicianAssistants/Pages/default.aspx
  14. GoodRx. Losartan prices in Pennsylvania. Accessed July 2025. https://www.goodrx.com/losartan
  15. Pennsylvania State Board of Pharmacy. Non-Resident Pharmacy Licensure. https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Pharmacy/Pages/default.aspx
  16. FDA. Drug Quality and Security Act (DQSA): Compounding. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act
  17. FDA. 503A vs 503B compounding: differences and requirements. https://www.fda.gov/drugs/human-drug-compounding/503a-and-503b-compounders
  18. Pennsylvania Department of Human Services. Preferred Drug List (PDL). Accessed July 2025. https://www.dhs.pa.gov/Services/Assistance/Pages/Preferred-Drug-List.aspx
  19. Pennsylvania Insurance Department. Step Therapy Reform Act (Act 146 of 2016). https://www.insurance.pa.gov/Consumers/Pages/HealthInsurance.aspx
  20. Pennsylvania State Board of Pharmacy. Emergency Dispensing and Prescription Transfer Rules. 49 Pa. Code §27.18. https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Pharmacy/Pages/default.aspx
  21. American Diabetes Association. Standards of Medical Care in Diabetes 2024. Section 10: Cardiovascular Disease and Risk Management. Diabetes Care. 2024;47(Suppl 1):S179-S218. https://pubmed.ncbi.nlm.nih.gov/38078591/
  22. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117(3):234-242. https://pubmed.ncbi.nlm.nih.gov/1616218/
  23. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
  24. Pennsylvania PACE/PACENET Program. Pennsylvania Department of Aging. Accessed July 2025. https://www.aging.pa.gov/aging-services/prescriptions/Pages/default.aspx
  25. NeedyMeds. Losartan patient assistance programs. Accessed July 2025. https://www.needymeds.org/